概括
新的组合疗法显著改善了晚期泌尿腺癌患者的存活率. 与单独化学疗法相比,结合恩福图马布 (enfortumab vedotin) 和潘布罗利祖马布 ( pembrolizumab) 的治疗几乎使整体存活率翻了一番.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
背景情况:
- 晚期或转移性尿路细胞癌具有重大临床挑战.
- 标准化疗对新诊断的晚期泌尿腺癌患者具有有限的疗效.
研究的目的:
- 评估在患有晚期或转移性尿路细胞癌的患者中新型组合疗法的疗效.
- 为了比较患者的结局与组合疗法与标准化疗.
主要方法:
- 总结了在2023年ESMO大会上报告的两项临床试验.
- 一项试验研究了恩福图马布维多丁 (一种抗体-药物合物) 和潘布罗利祖马布 (一种PD-1抑制剂) 的组合.
- 第二项试验评估了尼沃卢马布 (PD-1 抑制剂) 与标准化疗联合使用.
主要成果:
- 与标准化疗相比,Enfortumab vedotin加上 pembrolizumab 组合几乎使平均整体存活时间 (31.5 个月 vs 16.1 个月) 翻了一番.
- 尼沃卢马布和标准化疗的组合显示出优于单独标准化疗的优异结果.
- 这些发现代表了这一患者群体的平均整体存活率的首次显著改善.
结论:
- 组合疗法,包括抗体-药物合物和PD-1抑制剂,在晚期泌尿腺癌中表现出前所未有的疗效.
- 新的治疗策略为新诊断的患者提供了比传统化疗更好的生存益处.
- 这些结果突出了在治疗晚期泌尿腺癌的范式转变.
相关概念视频
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Endoscopic Studies II: Thoracocentesis
290
Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
290
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Standards of Care II
658
Nurses bear specific legal responsibilities under several federal statutes, including:
658


